UltraLinq Healthcare Solutions

UltraLinq Healthcare Solutions

QP-8.2.3-002 Medical Device Reporting Rev 1 -2016

The purpose of this procedure is to describe the organization's process of reporting adverse events to FDA.

Get Started
*You must pass each module to progress through this course.

Document Control
doccontrol@ultralinq.com

Modules in the Course:
QP-8.2.3-002 Medical Device Reporting Rev 1 -2016